Mirae Asset Global Investments Co., Ltd. Uni Qure N.V. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Uni Qure N.V. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,449 shares of QURE stock, worth $8,201. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,449
Previous 157,312
99.08%
Holding current value
$8,201
Previous $818,000
99.27%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding QURE
# of Institutions
141Shares Held
33.7MCall Options Held
1.54MPut Options Held
389K-
Vestal Point Capital, LP New York, NY4.75MShares$26.9 Million1.59% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.65MShares$15 Million0.79% of portfolio
-
Black Rock Inc. New York, NY1.93MShares$10.9 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY1.9MShares$10.8 Million0.78% of portfolio
-
Schroder Investment Management Group London, X01.74MShares$9.85 Million0.01% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $264M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...